Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EXTL3 antisense RNA 1 (EXTL3-AS1), also known as C8orf50, is a long non-coding RNA (lncRNA) gene located on chromosome 8, transcribed antisense to the EXTL3 gene[3]. It does not encode a protein and its molecular functions are not well characterized, but as with other lncRNAs, it may play a regulatory role in gene expression, potentially acting through interactions with other RNAs or chromatin. There is currently no evidence to suggest EXTL3-AS1 serves as a receptor, enzyme, transporter, or other direct therapeutic target, nor is it directly associated with disease states or drug interactions[3][6]. Context and clarification: - Although EXTL3-AS1 is frequently found in gene and expression profiling datasets as a non-coding RNA of interest, there are no data validating it as a receptor, enzyme, or any classical molecular target[3][6]. - It should not be confused with the protein-coding gene EXTL3, which encodes Exostosin-like glycosyltransferase 3, a glycosyltransferase involved in heparan sulfate biosynthesis and is associated with skeletal and immunological disorders[2][5].
Not applicable; not a therapeutic target or receptor, and no drug interactions described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EXTL3 antisense RNA 1 (EXTL3-AS1).